NCT06685276 2024-11-20Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal CancerChinese PLA General HospitalPhase 2 Recruiting46 enrolled